E
Essential Medical Research | Kansas City Metro
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
SAR445399
GIA632
Parent organization
This site is a part of Essential Medical Research
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 2 total trials
This study will evaluate the safety and efficacy of GIA632 in participants with moderate to severe cutaneous lichen planus (cLP).
Enrolling
Cutaneous Lichen Planus
Drug: GIA632
Drug: Placebo
This is a multinational, randomized, double-blind, placebo-controlled, Phase 2, dose finding study to evaluate the efficacy and safety of different d...
Enrolling
Hidradenitis Suppurativa
Drug: Placebo
Drug: SAR445399
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems